Proteomic analysis of oropharyngeal carcinomas reveals novel HPV‐associated biological pathways
Open Access
- 26 June 2012
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 132 (3) , 568-579
Abstract
Oropharyngeal carcinoma (OPC) can be classified into two equally prevalent subtypes depending on the presence of human papillomavirus (HPV). Patients with HPV‐positive (HPV+) OPC represent a unique cohort with a distinct tumor biology and clinical behavior compared to HPV‐negative (HPV−) OPC. Genetic studies have demonstrated chromosomal and gene expression changes associated with distinct subclasses of OPC; however, the proteomic consequences of HPV infection are not known. We analyzed sets of ten HPV+ and ten HPV− OPCs and ten normal adult oral epithelia using a standardized global proteomic analysis platform. This analysis yielded a total of 2,653 confidently identified proteins from which we chose 31 proteins on the basis of expression differences between HPV+, HPV− and normal epithelium for targeted protein quantitation. Analysis of differentially expressed proteins by HPV status revealed enrichment of proteins involved in epithelial cell development, keratinization and extracellular matrix organization in HPV− OPC, whereas enrichment of proteins in DNA initiation and replication and cell cycle control was found for HPV+ OPC. Enrichment analysis for transcription factor targets identified transcription factors E2F1 and E2F4 to be highly expressed in HPV+ OPC. We also found high expression of argininosuccinate synthase 1 in HPV+ OPC, suggesting that HPV+ OPC is more dependent on conditionally essential amino acid, arginine, and this was confirmed on a OPC‐specific tissue microarray. These identified proteomic changes reveal novel driving molecular pathways for HPV+ and HPV− OPCs that may be pertinent in therapeutic strategies and outcomes of OPC.Keywords
This publication has 47 references indexed in Scilit:
- Gene expression profiling in head and neck squamous cell carcinomaCurrent Opinion in Otolaryngology & Head and Neck Surgery, 2010
- Human Papillomavirus in Head and Neck Cancer: Its Role in Pathogenesis and Clinical ImplicationsClinical Cancer Research, 2009
- Equivalence of Protein Inventories Obtained from Formalin-fixed Paraffin-embedded and Frozen Tissue in Multidimensional Liquid Chromatography-Tandem Mass Spectrometry Shotgun Proteomic AnalysisMolecular & Cellular Proteomics, 2009
- Genomewide Gene Expression Profiles of HPV-Positive and HPV-Negative Oropharyngeal CancerJAMA Otolaryngology–Head & Neck Surgery, 2009
- Fundamental Differences in Cell Cycle Deregulation in Human Papillomavirus–Positive and Human Papillomavirus–Negative Head/Neck and Cervical CancersCancer Research, 2007
- Gene Expression Differences Associated with Human Papillomavirus Status in Head and Neck Squamous Cell CarcinomaClinical Cancer Research, 2006
- Genetic Patterns in Head and Neck Cancers That Contain or Lack Transcriptionally Active Human PapillomavirusJNCI: Journal of the National Cancer Institute, 2004
- Human Papillomavirus Type 16 and TP53 Mutation in Oral CancerCancer Research, 2004
- Human Papillomavirus Infection as a Risk Factor for Squamous-Cell Carcinoma of the Head and NeckNew England Journal of Medicine, 2001
- Human Papillomavirus and head and neck cancer: Epidemiology and molecular biologyHead & Neck, 1998